Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 49.30

-2.8%

Nov 20 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (4032)	6/6/2001 12:15:42 PM
From: Michael Young	Read Replies (1) of 52153

KOSP is really frustrating in many respects. They have a drug that meets a significant need in a fast growing market. And they only need a relatively small percentage of that market to send the stock to MUCH higher levels. Yet it is all about marketing muscle, and KOSP doesn't have it yet. MIKE

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next